Coenzyme Q10 for Alleviation of the Fatigue of Post Polio Syndrome

Phase 2

Completed

• Conditions: Excessive fatigue symptom of Post Polio Syndrome/Late Effects of Polio; Neurological - Other neurological disorders

• Registration Number: ACTRN12612000552886
• Lead Sponsor: Professor Marie Cooke

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-24
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

Polio survivors with Post Polio Syndrome or the Late Effects of Polio who attribute their excessive fatigue primarily to PPS/LEOP

Exclusion Criteria

Diagnosis with another medical condition that may account for the excessive fatigue, e.g. diabetes, anaemia, thyroid deficiency or fibromyalgia.
Treatment with warfarin since CoQ10 can redcue its effectiveness.
Those already taking CoQ10 on a regular basis

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
A statistically significant reduction in fatigue levels in the CoQ10 intervention group as compared to the placebo group, as assessed by the Fatigue Severity Scale (FSS) and the Multidimensional Assessment of Fatigue (MAF) Scale.[Two months after randomisation.]

Secondary Outcome Measures

Name	Time	Method
il[Nil]